HRP20080652T3 - Alpha-crystalline form of strontium ranelate, process of preparation thereof and pharmaceutical compositions containing it - Google Patents

Alpha-crystalline form of strontium ranelate, process of preparation thereof and pharmaceutical compositions containing it

Info

Publication number
HRP20080652T3
HRP20080652T3 HR20080652T HRP20080652T HRP20080652T3 HR P20080652 T3 HRP20080652 T3 HR P20080652T3 HR 20080652 T HR20080652 T HR 20080652T HR P20080652 T HRP20080652 T HR P20080652T HR P20080652 T3 HRP20080652 T3 HR P20080652T3
Authority
HR
Croatia
Prior art keywords
expressed
alpha
crystalline form
degrees
line
Prior art date
Application number
HR20080652T
Other languages
English (en)
Croatian (hr)
Inventor
Horvath St�phane
Demuynck Isabelle
Damien G�rard
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34942420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20080652(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20080652T3 publication Critical patent/HRP20080652T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Steroid Compounds (AREA)
HR20080652T 2004-09-30 2008-12-16 Alpha-crystalline form of strontium ranelate, process of preparation thereof and pharmaceutical compositions containing it HRP20080652T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410335A FR2875807B1 (fr) 2004-09-30 2004-09-30 Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
HRP20080652T3 true HRP20080652T3 (en) 2009-01-31

Family

ID=34942420

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080652T HRP20080652T3 (en) 2004-09-30 2008-12-16 Alpha-crystalline form of strontium ranelate, process of preparation thereof and pharmaceutical compositions containing it

Country Status (42)

Country Link
US (2) US7459568B2 (de)
EP (2) EP1944302A1 (de)
JP (2) JP2006104184A (de)
KR (1) KR100816590B1 (de)
CN (1) CN100391956C (de)
AP (1) AP1930A (de)
AR (1) AR049395A1 (de)
AT (1) ATE411308T1 (de)
AU (1) AU2005202718B2 (de)
BR (1) BRPI0502228A (de)
CA (1) CA2508824C (de)
CO (1) CO5710195A1 (de)
CR (1) CR7876A (de)
CY (1) CY1108797T1 (de)
DE (1) DE602005010359D1 (de)
DK (1) DK1642897T3 (de)
EA (1) EA008474B1 (de)
EC (1) ECSP055859A (de)
ES (1) ES2314593T3 (de)
FR (1) FR2875807B1 (de)
GE (1) GEP20074106B (de)
GT (1) GT200500130A (de)
HK (1) HK1086260A1 (de)
HR (1) HRP20080652T3 (de)
IL (1) IL169237A (de)
MA (1) MA27815A1 (de)
MX (1) MXPA05006407A (de)
NO (1) NO333948B1 (de)
NZ (1) NZ540802A (de)
OA (1) OA13013A (de)
PA (1) PA8638201A1 (de)
PE (1) PE20060364A1 (de)
PL (1) PL1642897T3 (de)
PT (1) PT1642897E (de)
RS (1) RS51110B (de)
SA (1) SA05260168B1 (de)
SG (1) SG121035A1 (de)
SI (1) SI1642897T1 (de)
TW (1) TWI367881B (de)
UA (1) UA80008C2 (de)
WO (1) WO2006035122A1 (de)
ZA (1) ZA200504937B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
CN101206208B (zh) * 2006-12-19 2011-08-10 北京德众万全药物技术开发有限公司 一种用hplc法分析雷尼酸锶原料及其制剂的方法
CN102227419A (zh) 2008-09-29 2011-10-26 拉蒂奥法姆有限责任公司 无水和水合形式的雷奈酸锶
IT1398542B1 (it) 2010-03-05 2013-03-01 Chemelectiva S R L Processo per la preparazione di un polimorfo
CN102241663B (zh) * 2010-05-10 2013-02-13 山东方明药业集团股份有限公司 一种雷奈酸锶八水合物的制备方法
WO2012143932A1 (en) * 2011-04-21 2012-10-26 Shilpa Medicare Limited Crystalline strontium ranelate form-s
CZ2011320A3 (cs) 2011-05-30 2012-12-12 Zentiva, K.S. Stabilní krystalická forma X stroncium ranelátu
EP2530068A1 (de) 2011-05-31 2012-12-05 Lacer, S.A. Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102503931A (zh) * 2011-09-20 2012-06-20 浙江华海药业股份有限公司 一种雷尼酸锶晶形h的制备方法
WO2013113319A1 (en) * 2012-01-31 2013-08-08 Pharmathen S.A. Process for the preparation of strontium ranelate, intermediate or hydrates thereof
EP2641905A1 (de) 2012-03-23 2013-09-25 Urquima S.A. Feste Formen von Strontiumranelat und Verfahren zu ihrer Herstellung
US8569514B1 (en) 2012-05-17 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of strontium ranelate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
ZA956029B (en) 1994-07-22 1997-01-20 Lilly Co Eli Combination treatment for inhibiting bone loss
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
DE19642451A1 (de) 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
US7629458B2 (en) * 2001-10-03 2009-12-08 Teva Pharmaceutical Industries Ltd. Preparation of levofloxacin and hemihydrate thereof
CA2471144C (en) * 2002-01-09 2011-06-07 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
JP2006508909A (ja) * 2002-08-06 2006-03-16 テバ ファーマシューティカル インダストリーズ リミティド ガチフロキサシンの新規な結晶形
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
CR7876A (es) 2007-12-10
FR2875807B1 (fr) 2006-11-17
CY1108797T1 (el) 2014-04-09
CA2508824C (fr) 2009-03-24
SG121035A1 (en) 2006-04-26
AU2005202718A1 (en) 2006-04-13
US20060069271A1 (en) 2006-03-30
CO5710195A1 (es) 2006-12-29
MA27815A1 (fr) 2006-04-03
NO333948B1 (no) 2013-10-28
GEP20074106B (en) 2007-05-10
KR100816590B1 (ko) 2008-03-24
EP1642897B1 (de) 2008-10-15
PE20060364A1 (es) 2006-06-17
JP2010132669A (ja) 2010-06-17
PT1642897E (pt) 2008-11-27
KR20060049966A (ko) 2006-05-19
NO20052998D0 (no) 2005-06-17
ZA200504937B (en) 2006-04-26
FR2875807A1 (fr) 2006-03-31
US20080312314A1 (en) 2008-12-18
CA2508824A1 (fr) 2006-03-30
SA05260168B1 (ar) 2009-02-25
HK1086260A1 (en) 2006-09-15
AP2005003323A0 (en) 2005-06-30
US7745482B2 (en) 2010-06-29
IL169237A (en) 2010-12-30
CN1754878A (zh) 2006-04-05
GT200500130A (es) 2005-12-20
EA008474B1 (ru) 2007-06-29
AR049395A1 (es) 2006-07-26
BRPI0502228A (pt) 2006-05-09
UA80008C2 (uk) 2007-08-10
SI1642897T1 (sl) 2009-02-28
TWI367881B (en) 2012-07-11
EP1642897A1 (de) 2006-04-05
AP1930A (en) 2008-12-15
TW200610758A (en) 2006-04-01
DK1642897T3 (da) 2009-01-26
AU2005202718B2 (en) 2010-09-16
ECSP055859A (es) 2006-09-18
EP1642897B9 (de) 2009-08-12
CN100391956C (zh) 2008-06-04
OA13013A (fr) 2006-11-10
PL1642897T3 (pl) 2009-04-30
RS51110B (sr) 2010-10-31
US7459568B2 (en) 2008-12-02
JP2006104184A (ja) 2006-04-20
ES2314593T3 (es) 2009-03-16
DE602005010359D1 (de) 2008-11-27
EP1944302A1 (de) 2008-07-16
PA8638201A1 (es) 2006-05-16
NO20052998L (no) 2006-03-31
ATE411308T1 (de) 2008-10-15
NZ540802A (en) 2006-11-30
EA200500842A1 (ru) 2006-04-28
WO2006035122A1 (fr) 2006-04-06
MXPA05006407A (es) 2006-04-05

Similar Documents

Publication Publication Date Title
HRP20080652T3 (en) Alpha-crystalline form of strontium ranelate, process of preparation thereof and pharmaceutical compositions containing it
HRP20080520T3 (en) Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
HRP20080418T3 (en) Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
HRP20080417T5 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
RS50598B (sr) Kristalni oblik gama ivabradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže
HRP20231588T3 (hr) Kombinacija koja sadrži stabilni kristal 4-oksokinolinskog spoja
RS51943B (en) PIPERIDINSKI GPCR AGONIST
BRPI0518068A (pt) composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada
RS54570B1 (en) NEW RIFAXIMIN POLYMORPH FORMS, PROCEDURE FOR THEIR PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS
YU100302A (sh) Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto
DE69505968D1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
DE60027700D1 (de) Bicyclische verbindungen und ihre verwendung als integrinrezeptorliganden
CN101077951B (zh) 一种以凹凸棒石粘土为主要成份的环保涂料
MXPA06001094A (es) Compuestos quimicos.
TW200833697A (en) Spiro-piperidine derivatives
BR0309120A (pt) Compostos com atividade antagonista de integrina alfa4
ATE304014T1 (de) Neue kristalline form eines pyrrolidylthiocarbapenem-derivates
IL117519A0 (en) Substituted benzothienylpiperazines their use as medicaments and processes for their preparation
NZ520155A (en) Thienopyridine derivatives, their production and use
TH101955B (th) รูปที่เป็นผลึกอัลฟาของสตรอนเซียมรานีเลท, กระบวนการสำหรับเตรียมสารนี้และสารผสมทางเภสัชกรรมที่ประกอบด้วยสารนี้
HRP20030125B1 (en) Prodrugs to nmda receptor ligands
Weil Single crystal growth of CaMg2 (SO4) 3 via solid‐/gas‐phase reactions and its Nasicon‐related crystal structure
寺井徹 et al. Synthesis of Cr (VI)-ettringite in portlandite suspensions as a function of pH
UY28969A1 (es) Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
TH81392A (de)